SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Hemoglobinopathies - Pipeline Review, H2 2013 Research Report

[February 05, 2014]

Research and Markets: Hemoglobinopathies - Pipeline Review, H2 2013 Research Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/5z974p/hemoglobinopathies) has announced the addition of the "Hemoglobinopathies - Pipeline Review, H2 2013" report to their offering.

'Hemoglobinopathies - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hemoglobinopathies, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hemoglobinopathies.

Scope

- A snapshot of the global therapeutic scenario for Hemoglobinopathies.

- A review of the Hemoglobinopathies products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till egistration stages.


- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Hemoglobinopathies pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Some Key Topics Covered:

Introduction

Hemoglobinopathies Overview

Therapeutics Development

Pipeline Products for Hemoglobinopathies - Overview

Pipeline Products for Hemoglobinopathies - Comparative Analysis

Hemoglobinopathies - Therapeutics under Development by Companies

Hemoglobinopathies - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Hemoglobinopathies - Products under Development by Companies

Hemoglobinopathies - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target (News - Alert)

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Assessment by Therapeutic Class

Drug Profiles

NiCord - Drug Profile

ZFP Transcription Factors For Hemoglobinopathies - Drug Profile

ALN-TMP - Drug Profile

Drug Targeting PRMT5 - Drug Profile

Drug Targeting Protein Arginine Methyltransferase 5 - Drug Profile

Hemoglobinopathies - Recent Pipeline Updates

Hemoglobinopathies - Product Development Milestones

Companies Mentioned

Sangamo BioSciences, Inc.

Gamida Cell Ltd.

Alnylam Pharmaceuticals, Inc.

Cancer Therapeutics CRC Pty Ltd

For more information visit http://www.researchandmarkets.com/research/5z974p/hemoglobinopathies

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy